6 results
P
breast cancer patients with Leptomeningeal Metastases (LM)
I/C
intrathecal trastuzumab administration, ????
O
clinical improvement, stabilization, CSF response, MRI improvement or stability, CNS-PFS, median OS
P
patients treated with a 1- versus a 2-stent strategy in LM bifurcation PCI
I/C
short-term DAPT, long DAPT, single stent strategy, double stent strategy
O
major adverse cardiovascular events (MACEs)
P
stable coronary artery disease (CAD) patients
I/C
coronary bypass (CABG), stenting, optimal medical therapy (OMT), OMT, CABG, durable-polymer-CoCr-everolimus-eluting stent, bio-absorbable-polymer-CoCr-sirolimus eluting stent
O
all-cause mortality, myocardial infarction (MI)
P
ADT-treated PCa patients
I/C
multidisciplinary interventions including exercise, diet, nutrition, pharmacotherapy, bariatric surgery, or psychological/behavioural therapy, no intervention
O
changes in body composition and MetS, prostate-specific antigen (PSA)
P
Africa, individuals
I/C
biopsy-proven primary glomerulonephritis, different histologic subtypes
O
prevalence of FSGS
P
patients with left main coronary artery disease
I/C
percutaneous coronary intervention (PCI) with drug-eluting stents, coronary artery bypass graft (CABG)
O
all-cause mortality, myocardial infarction (MI), stroke, repeated revascularization, periprocedural MI, nonperiprocedural MI